Marie Philipneri, MD
Nephrology · Saint Louis, MONPI 1144231770
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,800 of the $8,826 with a category attached, or 77.0%. Baxter Healthcare accounts for 92.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $8,248 and has fallen 96.0% since, to $333 in 2024.
Across 19 payments — averaging $464.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$8K
- Nxstage Medical, Inc.$221
- Acera Surgical, Inc.$132
- GSK$113
- Fresenius USA Marketing, Inc.$112
- Mallinckrodt Enterprises LLC$100
What the payments were for
- Consulting fees$6,80077%
- Travel & lodging$96411%
- Food & beverage$96211%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 14 | $8,148 |
| Nxstage Medical, Inc. | 1 | $221 |
| Acera Surgical, Inc. | 1 | $132 |
| GSK | 1 | $113 |
| Fresenius USA Marketing, Inc. | 1 | $112 |
| Mallinckrodt Enterprises LLC | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - HD$7,846
- NXSTAGE SYSTEM ONE$333
- Restrata Wound Matrix$132
- LIBERTY SELECT CYCLER$112
How this compares
$8,826 in reported general payments places this provider in the 85th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 18 | $27,080 |
| JardianceEmpagliflozin | 18 | $15,238 |
| VeltassaPatiromer Calcium Sorbitex | 11 | $14,572 |
| LokelmaSodium Zirconium Cyclosilicate | 14 | $12,201 |
| Sevelamer Carbonate | 20 | $5,335 |
| Calcium Acetate | 21 | $1,176 |
| Torsemide | 41 | $1,093 |
| Gentamicin Sulfate | 13 | $466 |
| Nifedipine ErNifedipine | 25 | $439 |
| Hydralazine Hcl | 56 | $383 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 18 | $357 |
| Potassium Chloride | 43 | $345 |
| Doxazosin Mesylate | 24 | $327 |
| Metolazone | 19 | $291 |
| Labetalol Hcl | 15 | $268 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Saint Louis
- Marcos RothsteinSaint Louis$350K
- Anuja JavaSaint Louis$240K
- Daniel CoyneSaint Louis$163K
- Tarek AlhamadSaint Louis$155K
- Tingting LiSaint Louis$130K
- Krista LentineSaint Louis$86K
- Rowena Delos SantosSaint Louis$30K
- Kabeya MwintshiSaint Louis$25K
- Naoka MurakamiSaint Louis$24K
- Benjamin HumphreysSaint Louis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.